Pharmacological Prophylaxis and Management of Adult Postoperative/Postdischarge Nausea and Vomiting

Journal of Perianesthesia Nursing

Volumn 21, Issue 6, 2006, Pages 385-397

  Golembiewski, Julie ^a   Tokumaru, Sheri ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT;

ADULT; ARTICLE; DRUG COMBINATION; HOSPITAL DISCHARGE; HUMAN; POSTOPERATIVE NAUSEA AND VOMITING; RISK ASSESSMENT;

ADULT; ANTIEMETICS; DRUG THERAPY, COMBINATION; HUMANS; PATIENT DISCHARGE; POSTOPERATIVE NAUSEA AND VOMITING; RISK ASSESSMENT;

EID: 33845339650     PISSN: 10899472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jopan.2006.09.004     Document Type: Article

References (65)

1. Koivuranta M., Läärä E., Snåre L., et al. A survey of postoperative nausea and vomiting. Anaesthesia 52 (1997) 443-449
2. Apfel C., Läärä E., Koivuranta M., et al. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology 91 (1999) 693-700
3. Apfel C.C., Kranke P., Katz M.H., et al. Volatile anesthetics may be the cause of early but not delayed postoperative vomiting: A randomized controlled trial of factorial design. Br J Anaesth 88 (2002) 659-668
4. Tramèr M.R. A rational approach to the control of postoperative nausea and vomiting: Evidence from systematic reviews. Part 1. Efficacy and harm of antiemetic interventions, and methodological issues. Acta Anaesthesiol Scand 45 (2001) 4-13
5. Kovac A.L. Prevention and treatment of postoperative nausea and vomiting. Drugs 59 (2000) 213-243
6. ASHP Commission on Therapeutics. ASHP therapeutics guidelines on the pharmacologic management of nausea and vomiting in adult pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm 56 (1999) 729-764
7. Ockner R.K. Introduction to gastrointestinal disease. In: Bennett J.C., and Plum F. (Eds). Cecil Textbook of Medicine. 20th ed (1996), WB Saunders Co, Philadelphia, PA 627-630
8. Watcha M.F., and White P.F. Postoperative nausea and vomiting. Anesthesiology 77 (1992) 162-184
9. American Gastroenterological Association. AGA technical review on nausea and vomiting. Gastroenterology 120 (2001) 263-286
10. Bailey P.L., Egan T.D., and Stanley T.H. Intravenous opioid anesthetics. In: Miller R.D. (Ed). Anesthesia. 5th ed (2000), Churchill Livingstone, Philadelphia, PA 273-376
11. Saito R., Takano Y., and Kamiya H.O. Roles of substance P and NK(1) receptor in the brainstem in the development of emesis. J Pharmacol Sci 91 (2003) 87-94
12. Hornby P.J. Central neurocircuitry associated with emesis. Am J Med 111 (2001) 106S-112S
13. Fortney J.T., Gan T.J., Graczyk S., et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. Anesth Analg 86 (1998) 731-738
14. Henzi I., Sonderegger J., and Tramèr M.R. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anesth 47 (2000) 537-551
15. Wallenborn J., Gelbrich G., Bulst D., et al. Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: Randomised double blind multicentre trial. BMJ 333 (2006) 324
16. Henzi I., Walder B., and Tramèr M.R. Metoclopramide in the prevention of postoperative nausea and vomiting: A quantitative systematic review of randomized, placebo-controlled studies. Br J Anaesth 83 (1999) 761-771
17. Tramèr M.R., Reynolds D.J., Moore R.A., et al. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: A quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 87 (1997) 1277-1289
18. Mikawa K., Takao Y., Nishina K., et al. Optimal dose of granisetron for prophylaxis against postoperative emesis after gynecological surgery. Anesth Analg 85 (1997) 652-656
19. Apfel C.C., Kortilla K., Abdalla M., et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 350 (2004) 2441-2451
20. Food and Drug Administration. Important drug warning letter from Akorn Pharmaceuticals (2006). http://www.fda.gov/medwatch/safety/2001/inapsine.htm Available at: http://www.fda.gov/medwatch/safety/2001/inapsine.htm. Accessed August 19
21. White P.F., Song D., Abroa J., et al. Effect of low-dose droperidol on the QT interval during and after general anesthesia. Anesthesiology 102 (2005) 1101-1105
22. Perrault L.P., Denault A.Y., Carrier M., et al. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery. Can J Anaesth 47 (2000) 251-254
23. Domino K.B., Anderson E.A., and Polissar N.L. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: A meta-analysis. Anesth Analg 88 (1999) 1370-1379
24. Holesha W., and Dziura-Murauski J. Extrapyramidal side effects of metoclopramide in outpatient surgical patients. J Post Anesth Nurs 9 (1994) 107-110
25. Chen J.J., Frame D.G., and White T.J. Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures. Arch Intern Med 158 (1998) 2124-2128
26. Khalil S., Philbrook L., Rabb M., et al. Ondansetron/promethazine combination or promethazine alone reduces nausea and vomiting after middle ear surgery. J Clin Anesth 11 (1999) 596-600
27. Altman D.F. Drugs used in gastrointestinal diseases. In: Katzung B.G. (Ed). Basic and Clinical Pharmacology. 8th ed (2001), McGraw-Hill, New York 1064-1076
28. Kranke P., Morin A.M., Roewer N., et al. Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: A meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand 46 (2002) 238-244
29. Clissold S.P., and Heel R.C. Transdermal hyoscine (scopolamine): A preliminary review of its pharamacodynamic properties and therapeutic efficacy. Drugs 29 (1985) 189-207
30. Wang E.T., Zhou D.R., and He L.H. Histaminergic response to coriolis stimulation: Implication for transdermal scopolamine therapy of motion sickness. Aviat Space Environ Med 63 (1992) 579-582
31. Takeda N., Morita M., Horii A., et al. Neural mechanisms of motion sickness. J Med Invest 48 (2001) 44-59
32. Harris S.N., Sevarino F.B., Sinatra R.S., et al. Nausea prophylaxis using transdermal scopolamine in the setting of patient-controlled analgesia. Obst Gynecol 78 (1991) 673-677
33. Ferris F.D., Kerr I.G., Sone M., et al. Transdermal scopolamine use in the control of narcotic-induced nausea. J Pain Symptom Manag 6 (1991) 389-393
34. Kranke P., Morin A.M., Roewer N., et al. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: A quantitative systematic review. Anesth Analg 95 (2002) 133-143
35. Novartis. Prescribing information: Transderm Scop (transdermal scopolamine). Novartis Consumer Health, Inc. Available at: http://www.transdermscop.com/infomed_prescribing.htm. Accessed August 27, 2006
36. Figueredo E.D., and Canosa L.G. Ondansetron in the prophylaxis of postoperative vomiting: A meta-analysis. J Clin Anesth 10 (1998) 211-221
37. Philip B.K., McLeskey C.H., Chelly J.E., et al. Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. J Clin Anesth 12 (2000) 1-8
38. Roche Pharmaceuticals. Kytril package insert (2005), Roche Pharmaceuticals, Nutley, NJ
39. 3 receptor antagonist, for preventing postoperative nausea and vomiting after hysterectomy procedures. Anesth Analg 87 (1998) 462-467
40. Gan T.J. Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: Are they all the same? 19 (2005) 225-238
41. Kuryshev Y.A., Brown A.M., Wang L., et al. Interactions of the 5-hydroxytryptamine3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther 295 (2000) 614-620
42. Navari R.M., and Koeller J.M. Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists. Ann Pharmacother 37 (2003) 1276-1286
43. Harris A.L. Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways. Lancet 1 (1982) 714-716
44. Henzi I., Walder B., and Tramèr M.R. Dexamethasone for the prevention of postoperative nausea and vomiting: A quantitative systematic review. Anesth Analg 90 (2000) 186-194
45. Merck. Decadron package insert (2004), Merck & Co., Inc, Whitehouse Station, NJ
46. Bleiberg H. A new class of antiemetics: The NK-1 receptor antagonists. Curr Opin Oncol 12 (2000) 284-288
47. Gan T.J., Apfel C., and Kovac A. The NK1 receptor antagonist aprepitant for prevention of postoperative nausea and vomiting (2005), American Society of Anesthesiologists Meeting Abstract A769. October 24
48. Merck. Emend package insert (2006), Merck & Co., Inc, Whitehouse Station, NJ
49. Smith I., White P.F., Nathanson M., et al. Propofol. An update on its clinical use. Anesthesiology 81 (1994) 1005-1043
50. Tramèr M.R., Moore A., and McQuay H.J. Propofol anaesthesia and postoperative nausea and vomiting: Quantitative systematic review of randomized studies. Br J Anaesth 78 (1997) 247-255
51. Borgeat A., Ekatodramis G., and Schenker C.A. Postoperative nausea and vomiting in regional anesthesia. Anesthesiology 98 (2003) 530-547
52. Roberts G.W., Bekker T.B., Carlsen H.H., et al. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg 101 (2005) 1343-1348
53. Marret E., Kurdi O., Zuffrey P., et al. Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: Meta-analysis of randomized controlled trials. Anesthesiology 102 (2005) 1249-1260
54. Ali S.Z., Taguchi A., Holtmann B., et al. Effect of supplemental pre-operative fluid on postoperative nausea and vomiting. Anaesthesia 58 (2003) 780-784
55. Holte K., Klarskov B., Christensen D.S., et al. Liberal versus restrictive fluid administration to improve recovery after laparoscopic cholecystectomy: A randomized, double-blind study. Ann Surg 240 (2004) 892-899
56. Kazemi-Kjellberg F., Henzi I., and Tramèr M.R. Treatment of established postoperative nausea and vomiting: A quantitative systematic review. BMC Anesthesiol 1 (2001) 2
57. Tramèr M.R., Moore R.A., Reynolds, et al. A quantitative systematic review of ondansetron in treatment of established postoperative nausea and vomiting. BMJ 314 (1997) 1088-1092
58. Moser J.D., Caldwell J.B., and Rhule F.J. No more than necessary: Safety and efficacy of low-dose promethazine. Ann Pharmachother 40 (2006) 45-48
59. Kovac A., O'Connor T.A., Pearman M.H., et al. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: A randomized, double-blind, placebo controlled multicenter trial. J Clin Anesth 11 (1999) 453-459
60. Habib A.S., and Gan T.J. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report. J Clin Anesth 17 (2005) 62-65
61. American Society of PeriAnesthesia Nurses. Evidence-based clinical practice guideline for the prevention and/or management of PONV/PDNV. J PeriAnesth Nurs 21 (2006) 230-250
62. Carroll N.V., Miederhoff P., Cox F.M., and Hirsch J.D. Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg 80 (1995) 903-909
63. Gan T.J. Postoperative nausea and vomiting: Can it be eliminated?. JAMA 13 (2002) 1233-1236
64. Gupta A., Wu C.L., Elkassabany N., et al. Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery?. Anesthesiology 99 (2003) 488-495
65. Gan T.J., Franiak R., and Reeves J. Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery. Anesth Analg 94 (2002) 1199-1200